Our research results first showed inhibition of TGF‐β receptor type I/II and phosphorylation of Smad3 suppresses proliferation of CEA‐regulated oncolytic adenovirus CD55 in HCC (Fig. S1). The gene discussed is CD55; the disease is hepatocellular carcinoma.